17 Jul, EOD - Indian

Nifty Next 50 68711.45 (-0.23)

Nifty IT 37138.55 (-1.39)

Nifty Smallcap 100 19117.3 (-0.12)

SENSEX 82259.24 (-0.45)

Nifty 50 25111.45 (-0.40)

Nifty Bank 56828.8 (-0.59)

Nifty Midcap 100 59519.1 (-0.17)

Nifty Pharma 22680.35 (0.38)

17 Jul, EOD - Global

NIKKEI 225 39901.19 (0.60)

HANG SENG 24498.95 (-0.08)

S&P 6323.42 (0.62)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoRaymed Labs Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 531207 | NSE Symbol : | ISIN : INE741C01017 | Industry : Pharmaceuticals - Indian - Formulations |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
15-May-2025 22-May-2025 Quarterly Results Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve Financial results of the company for quarter and year ended 31st March 2025 Please find the attached outcome of Board Meeting. (As per BSE Announcement Dated on 22/05/2025)
25-Mar-2025 25-Mar-2025 Change in Company Name Please find the attached Outcome of the Board Meeting held today i.e., 25th March, 2025 Please find the attached outcome of Board Meeting held on 25th March, 2025 in which the Board of Directors of the Company has appointed Ms. Komal Bajaj, as the Internal Auditor of the Company.
01-Feb-2025 01-Feb-2025 Change in Directors Please find the attached Outcome of Board Meeting.
22-Jan-2025 27-Jan-2025 Quarterly Results RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve the agenda items mentioned in the attached Intimation Please find the attached Intimation for change in Directors Outcome of Board Meeting held on 27th January, 2025 Results for the financial year ended 31st December 2024 (As Per Bse Announcement Dated on 27.01.2025)
08-Jan-2025 08-Jan-2025 Change in Directors Outcome of Board Meeting for Appointment of Directors Outcome of Board Meeting held for Appointment of Additional Directors
28-Oct-2024 06-Nov-2024 Quarterly Results Quarterly Results Approval of unaudited standalone Financial results for the quarter and half year ended 30 september 2024 Appointment of Additional Director and Company Secretary Approval of Unaudited Standalone Financial Results for Quarter and Half Year ended 30 September 2024 (As per BSE Announcement Dated on 06/11/2024)
23-Aug-2024 23-Aug-2024 Change in Other Executives Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Resignation of Company Secretary & Compliance Officer
05-Aug-2024 12-Aug-2024 Quarterly Results RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Un-Audited Standalone Financial Results for the quarter ended June 30 2024 Approval of Un-audited Quarterly Financial Results for the quarter ended June 30, 2024
13-May-2024 24-May-2024 Accounts RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve Audited Standalone Financial Results as per Regulation 33 of SEBI (LODR) Regulations 2015 for the quarter and year ended March 31 2024 Approval of Audited Standalone Financial Results for the quarter and year ended March 31, 2024 Outcome of Board Meeting Dated 24/05/2024 (As Per BSE Announcement Dated on 24/05/2024)
17-Apr-2024 17-Apr-2024 Change in Registered Address Outcome of Board Meeting pursuant to under Regulation 30 of SEBI (LODR) Regulations, 2015- change in Registered office of the Company within Local Limits
25-Jan-2024 06-Feb-2024 Quarterly Results RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve Unaudited Standalone Financial Results for the Quarter ended 31st December 2023. Approval of Unaudited Stanalone Financial Result for the Quarter ended 31st December 2023 of Raymed Labs Limited (As Per BSE Announcement Dated on: 06/02/2024) Intimation under Regulation 30 of SEBI LODR Regulation , 2015 -Newspaper Publication (As Per BSE Announcement Dated on 07/02/2024)
15-Dec-2023 15-Dec-2023 Others Intimation under Regulation 30(5) of SEBI LODR Regulations 2015-Authorisation & Contact details of Key Managerial Personnel of the Company
27-Oct-2023 04-Nov-2023 Quarterly Results RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Unaudited Standalone Financial Results as per Regulation 33 of SEBI (LODR) Regulations 2015 for quarter and half year ended September 30 2023 together with the Limited Review Report. Un-audited Standalone Financial Results for the quarter and half year ended September 30, 2023 Outcome of Board Meeting for approval of Un-audited Financial Results for the Quarter and Half Year ended September 30, 2023 Outcome of Board Meeting dated 04/11/2023 (As Per BSE Announcement Dated on 04/11/2023)
22-Jul-2023 02-Aug-2023 Quarterly Results RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 inter alia to consider and approve unaudited financial results for quarter ended June 30 2023 Approval of Unaudited Standalone Financial Results for the Quarter ended 30.06.2022 Outcome of Board Meeting held on 02.08.2023 Book Closure dated from Saturday, 26th Day of August 2023 to Friday, the 1st day of September, 2023(both days inclusive) (As Per BSE Announcement dated on 02.08.2023) Revised Unaudited Standalone Financial Results for quarter ended 30th June, 2023 (As Per BSE Announcement dated on 08.08.2023)
12-May-2023 27-May-2023 Accounts RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve 1. The Audited Standalone Financial Results as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the quarter and year ended March 31 2023 together with the Audit Report. 2. To consider and approve the appointment of Secretarial Auditor of the Company for the financial year 2022-23. 3. To take note on Disclosure of Related Party Transactions on a consolidated basis as required under Regulation 23(9) of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 for half year ended March 31 2023. Outcome of Board Meeting for approval of Audited Standalone Financial Results for quarter and year ended March 31, 2023 Outcome of Board Meeting held on May 27, 2023 (As Per BSE Announcement Dated on 27.05.2023)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-8657545825
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
subscription@capitalmarket.com

For Capital Market Online Product related queries :
financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +